These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8810818)

  • 1. [Successful treatment in a case of type-C fulminant hepatitis with interferon and steroid-pulse therapy, and review of its virological aspects].
    Marusawa H; Yamashita Y; Kajimura K; Kumegawa Y; Takaya H; Katsurada A
    Nihon Shokakibyo Gakkai Zasshi; 1996 Aug; 93(8):583-7. PubMed ID: 8810818
    [No Abstract]   [Full Text] [Related]  

  • 2. Three times weekly versus daily dose alpha-interferon treatment in patients with acute hepatitis C.
    Fabris P; Tositti G; Giordani MT; Infantolino D; de LF
    Am J Gastroenterol; 2002 Feb; 97(2):492-3. PubMed ID: 11866300
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of combination therapy with interferon and azidothymidine in chronic type C hepatitis: a pilot study.
    Tsutsumi M; Takada A; Sawada M
    J Gastroenterol; 1995 Aug; 30(4):485-92. PubMed ID: 7550859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hepatitis C-virus-reinfection after liver transplant with silibinin in nonresponders to pegylated interferon-based therapy.
    Eurich D; Bahra M; Berg T; Boas-Knoop S; Biermer M; Neuhaus R; Neuhaus P; Neumann U
    Exp Clin Transplant; 2011 Feb; 9(1):1-6. PubMed ID: 21605016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of interferon alpha in acute hepatitis C in patients on chronic hemodialysis.
    Süleymanlar I; Sezer T; Işitan F; Yakupoglu G; Süleymanlar G
    Nephron; 1998; 79(3):353-4. PubMed ID: 9678442
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hepatitis C].
    Moradpour D; Blum HE
    Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current knowledge in the treatment of chronic hepatitis C].
    Pirotte J
    Rev Med Liege; 1995 Dec; 50(12):501-4. PubMed ID: 8570988
    [No Abstract]   [Full Text] [Related]  

  • 8. [Guidelines for treatment of hepatitis C].
    Iino S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):342-6. PubMed ID: 15359818
    [No Abstract]   [Full Text] [Related]  

  • 9. Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C.
    Teuber G; Berg T; Hoffmann RM; Leifeld L; Lafrenz M; Spengler U; Pape GR; Hopf U; Zeuzem S
    Digestion; 2000; 61(2):90-7. PubMed ID: 10705172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and virological changes in serum of nonresponder or relapser chronic hepatitis C patients retreated with interferon and ribavirin followed by interferon alone.
    Cuccorese G; Tursi A; Spinazzola AM; Modeo ME; Miglietta A
    Am J Gastroenterol; 2000 Sep; 95(9):2399-400. PubMed ID: 11007262
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study.
    Tan AC; Brouwer JT; Glue P; van Leusen R; Kauffmann RH; Schalm SW; de Vries RA; Vroom B
    Nephrol Dial Transplant; 2001 Jan; 16(1):193-5. PubMed ID: 11209032
    [No Abstract]   [Full Text] [Related]  

  • 12. Reversible myopathy during successful treatment with pegylated interferon and ribavirin for acute hepatitis C.
    Golstein PE; Delforge ML; Deviere J; Marcellin P
    J Viral Hepat; 2004 Mar; 11(2):183-6. PubMed ID: 14996354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Virological sustained response to former young intravenous drug abusers with chronic hepatitis C treated by pegylated interferon-α plus ribavirin].
    Gazdíková K; Gazdík F; Kajaba I; Hučková D; Daniš D; Okruhlica L
    Vnitr Lek; 2012 Feb; 58(2):104-9. PubMed ID: 22463089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hepatitis C infection: an indication for alfa interferon therapy?
    van der Vlies CH; Tang TJ; Niesters HG; Zondervan PE; Janssen HL; de Man RA
    Neth J Med; 2000 Jul; 57(1):30-3. PubMed ID: 10863000
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of dialysis patients with chronic hepatitis C using pegylated interferon and low-dose ribavirin.
    Carriero D; Fabrizi F; Uriel AJ; Park J; Martin P; Dieterich DT
    Int J Artif Organs; 2008 Apr; 31(4):295-302. PubMed ID: 18432584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-treatment of patients with hepatitis C who failed to respond (nonresponders) to previous treatment.
    Sharvadze LG; Gogichaishvili ShSh; Sakandelidze TsG; Zhamutashvili MT; Chkhartishvili NI
    Georgian Med News; 2009 Jan; (166):61-4. PubMed ID: 19202222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological and clinical study for hepatitis C virus infection].
    Hayashi J; Furusyo N
    Fukuoka Igaku Zasshi; 2010 Mar; 101(3):46-52. PubMed ID: 20653197
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon alpha-2b in combination with ribavirin for the treatment of chronic hepatitis C: assessment of virological, biochemical and histological treatment response.
    Petrenkiene V; Gudinaviciene I; Jonaitis L; Kupcinskas L
    Medicina (Kaunas); 2004; 40(6):538-46. PubMed ID: 15208476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon and steroid treatment in patients with chronic hepatitis C and antinuclear or anti-liver-kidney microsomal antibodies.
    Provenzano G; Almasio P; Fabiano C; Magrin S; Pinzello G; Vaccaro A; Craxì A
    Ital J Gastroenterol; 1996 Sep; 28(7):377-80. PubMed ID: 8937938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonresponder patients with hepatitis C virus genotype 2/3 infection: a question of low systemic interferon concentrations?
    Alsiö A; Christensen PB; Färkkilä M; Langeland N; Buhl MR; Pedersen C; Mørch K; Haagmans BL; Westin J; Hellstrand K; Norkrans G; Lagging M
    Clin Infect Dis; 2010 Feb; 50(4):e22-5. PubMed ID: 20088695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.